Clinical Trials Logo

Filter by:
NCT ID: NCT05871320 Completed - Clinical trials for Neuroendocrine Tumors

Novel 99mTc-labeled Somatostatin Antaginosts in the Diagnostic Algotithm of Neuroendocrine Neoplasms

TECANT
Start date: December 23, 2022
Phase: Early Phase 1
Study type: Interventional

The main goal of the study is to expand cancer preclinical research results on the usefulness of SSTR2-Antagonist [99mTc]Tc-TECANT1 in clinical practice. Detection of NEN and monitoring of response to therapy is still challenging due to their cellular heterogeneity. Initial preclinical studies suggest that NEN imaging with the use of SSTR2-Antagonist may be advantageous in comparison to the widely used SSTR2-Agonists. Recently, novel radiopharmaceuticals, based on SSTR2-Antagonists, were shown to provide superior SSTR2 visualisation than currently used agonists. The need for molecular imaging of NEN is expected to grow significantly in the near future due to their increasing incidence and prevalence. Although a persistent trend to shift the molecular imaging of NEN from conventional SPECT/CT gamma cameras to PET/CT has been observed in the last decade, labelling the compound with Tc-99m offers significant advantages by its extremely wide availability, low cost and low radiation exposure to patients. Effective and accessible molecular imaging methods as an integral part of personalised patient management are needed to optimise selection and follow-up of available therapeutic modalities. The Tc-99m-labeled SSTR2-Antagonist [99mTc]Tc-TECANT1 is expected to be an effective, widely available compound for quantitative assessment of SSTR2 NEN status, allowing a personalised therapeutic approach.

NCT ID: NCT05871112 Completed - Knee Osteoarthritis Clinical Trials

Femoral Rotation and Patellar Positioning After TKA

Start date: January 4, 2021
Phase:
Study type: Observational

Analysis of patellar positioning in the trochlear groove after TKA with and without the use of dynamic tensioner.

NCT ID: NCT05861700 Completed - Clinical trials for Acid-Base Balance Disorder

The Effect of Bicarbonate Profiling in Dialysis Fluid on Phosphate Removal During Hemodialysis and Blood pH

Start date: May 21, 2018
Phase: N/A
Study type: Interventional

Hyperphosphatemia is still an unresolved problem among hemodialysis patients and significantly increases the risk of death from cardiovascular diseases. Research to date has not answered the question of whether dialysate bicarbonate concentration profiling can improve phosphate removal and its concentration without negative impact on the acid-base balance. This study addressed this issue. Twenty stable hemodialysis patients will enroll to a four-week study during which different dialysate bicarbonate concentration profiles will be used each week. Each patient will undergo the following profiles (one-week periods): Treatment A - stable dialysate bicarbonate concentration Dbic 35 mmol/L during the whole HD session, Treatment B - Dbic 35 mmol/L for the first two hours and Dbic 30 mmol/L for the next two hours and Treatment C - the opposite mid-HD change Dbic from 30 to 35 mmol/L and one week wash-out period between Treatment B and C. We will collect blood samples each hour during the session and one hour after HD completion.

NCT ID: NCT05861349 Completed - Clinical trials for Carpal Tunnel Syndrome

Median Nerve Stenosis in Carpal Tunnel Syndrome

Start date: November 1, 2023
Phase:
Study type: Observational

The goal of this observational study is to test the new kind of ultrasound-based measurements in patients with carpal tunnel syndrome. The main questions it aims to answer are: - Do the measurements of the size of the median nerve at the point where it is maximally compressed accurately diagnose carpal tunnel syndrome? - May these measurements accurately tell how severe is the carpal tunnel syndrome? Participants will be asked to: - Undergo conduction studies of median and ulnar nerve. - Undergo ultrasound of the median nerve. - Fill out the Boston carpal tunnel questionnaire and a demographic questionnaire. Researchers will compare the group of patients with carpal tunnel syndrome with healthy volunteers to see if respective measurements differ significantly between groups.

NCT ID: NCT05844800 Completed - Pectus Excavatum Clinical Trials

The Effect of Surgical Repair of Chest on Postural Stability Among Patients With Pectus Excavatum

Start date: January 2011
Phase: N/A
Study type: Interventional

The goal of this study is to determine the effect of Nuss minimally-invasive repair technique of pectus excavatum (PE) on the postural stability in patients with PE. The main questions it aims to answer are: - How surgical chest wall repair will affect postural stability of PE patients? - What is the difference in postural stability between patients with PE and healthy controls? Participants will undergo the Nuss repair surgery and will be tested before and afterwards for their postural stability with the use of the posturography method. Researchers will compare PE male patients and healthy young men to see if PE posture defect affects postural stability.

NCT ID: NCT05843617 Completed - Clinical trials for Bioavailability of Vitamin C

Comparison of Bioavailability of Liposomal and Traditional Formulation of Vitamin C

Start date: February 28, 2022
Phase: N/A
Study type: Interventional

The aim of the study was to compare the profiles of vitamin C serum concentration in healthy volunteers after the single oral administration either in a liposomal (Liposovit-C pure) or traditional formulation.

NCT ID: NCT05839574 Completed - Clinical trials for Cesarean Scar Pregnancy

Letrozole add-on in the Treatment of Cesarean Scar Pregnancy

Start date: January 1, 2021
Phase: N/A
Study type: Interventional

It is hypothesized that the inhibition of estradiol production by letrozole may interfere with physiological effects of progesterone necessary to maintain the pregnancy. There is no reference treatment of cesarean scar pregnancy (CSP) as the limited number of cases precludes the extrapolation of results. In our center we successfully use two-step treatment with methotrexate (MTX) followed by hysteroscopic removal of products of conception (POC). The time in between is needed to achieve a decrease in the trophoblast's vital potential (B-hCG fall) and its vascularization. Additional administration of letrozole could further reduce the vital potential of the pregnancy, eliminating the need for another dose of MTX, resulting in faster healing and lower rate of complications.

NCT ID: NCT05839561 Completed - Clinical trials for Tubal Pregnancy Unruptured

Monotherapy With Letrozole in Tubal Pregnancy

Start date: December 1, 2020
Phase: N/A
Study type: Interventional

It is hypothesized that the inhibition of estradiol production by letrozole may interfere with physiological effects of progesterone necessary to maintain the pregnancy. Treatment of tubal pregnancy with letrozole would allow to avoid the adverse effects of methotrexate (MTX) in women refusing surgery. The aim was to compare the effectiveness of letrozole with MTX in the management of tubal pregnancy.

NCT ID: NCT05829850 Completed - Clinical trials for Osteo Arthritis Knee

An Effectiveness and Safety 6 Months Study of 3 Injections One Week Apart of SYNOLIS VA 40/80 in the Treatment of Symptomatic Knee Osteoarthritis

Start date: December 29, 2021
Phase: N/A
Study type: Interventional

Multicentre, independent assessment study on SYNOLIS VA 40/80 over a period of 24 weeks

NCT ID: NCT05829798 Completed - Clinical trials for Osteoarthritis, Knee

An Efficacy and Safety 6-months Study of SYNOLIS VA 80/160 and SYNOLIS VA 40/80 in the Treatment of Symptomatic Knee Osteoarthritis

Start date: January 14, 2021
Phase: N/A
Study type: Interventional

Multicentre, independent assessment study on SYNOLIS VA 80/160 and SYNOLIS VA 40/80 over a period of 24 weeks